J. McEvoy

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
J. Mcevoy, J. William Mcevoy, John William Mcevoy, John Mcevoy, Johnw. Mcevoy, J William Mcevoy, John W. Mcevoy, John W Mcevoy
Publication record
357 papers · 20,776 citations · H-index 52

PAPERS

Abstract P416: Higher Quality Diet is Associated With Lower Serum Levels of NT-proBNP
20230 citationsauthor #6
High-Sensitivity Troponin T and I Among Pregnant Women in the US-the National Health and Nutrition Examination Survey, 1999-2004.
202314 citationsauthor #5
High-sensitivity troponins and mortality in the general population
202358 citationsauthor #1
Behaviour change techniques and intervention characteristics in digital cardiac rehabilitation: a systematic review and meta-analysis of randomised controlled trials
202317 citationsauthor #3
Subclinical Cardiovascular Disease in US Adults With and Without Diabetes
202321 citationsauthor #4
Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adults
202310 citationsauthor #5
DETERMINANTS OF INCIDENT STROKE AMONG THOSE WITH ABSENT CORONARY ARTERY CALCIFICATION: RESULTS FROM THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS
20230 citationsauthor #11
Instrumental variables, in silico trial simulation, and cutting-edge analysis in cardiology: with great power comes great responsibility.
20231 citationsauthor #2
Associations between diet quality and NT-proBNP in U.S. adults, NHANES 1999-2004
202314 citationsauthor #6
Prevalence and Correlates of Elevated NT-proBNP in Pregnant Women in the General U.S. Population
202317 citationsauthor #9
Age‐Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease
202336 citationsauthor #18
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe
2023184 citationsauthor #49
Supporting GPs and people with hypertension to maximise medication use to control blood pressure: Protocol for a pilot cluster RCT of the MIAMI intervention
20233 citationsauthor #14
Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control- National Health and Nutrition Examination Survey, 1999-2004
20231 citationsauthor #2
Elevated Cardiac Biomarkers, Erectile Dysfunction, and Mortality in U.S. Men
20237 citationsauthor #6
Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in a Population-Based Sample of US Children and Adolescents
202315 citationsauthor #1
Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetes.
20238 citationsauthor #5
The 2017 ACC/AHA Hypertension Guideline and Blood Pressure in Older Adults.
20233 citationsauthor #6
NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study
202326 citationsauthor #4
Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control.
20239 citationsauthor #2
Associations of N-Terminal Pro-B-Type Natriuretic Peptide, Estimated Glomerular Filtration Rate, and Mortality in US Adults.
20239 citationsauthor #4
Harnessing digital health to optimise the delivery of guideline-based cardiac rehabilitation during COVID-19: an observational study
202310 citationsauthor #9
NT-proBNP Reference Intervals in Healthy U.S. Children, Adolescents, and Adults.
202319 citationsauthor #7
Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults.
202324 citationsauthor #1
Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease
202320 citationsauthor #7
Body Composition Measures and N-terminal pro-B-type Natriuretic Peptide (NT-pro-BNP) in US Adults.
20232 citationsauthor #3
Letter by Gibson and McEvoy Regarding Article, "Influence of Age on the Diagnosis of Myocardial Infarction".
20230 citationsauthor #2
Glycated Albumin and Risk of Mortality in the US Adult Population.
20224 citationsauthor #4
Corrigendum to 'Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study': [The American Journal of Medicine (2022) Volume 136(12), 1461-1467].
20220 citationsauthor #3
Another Nail in the Coffin of Causality for the Diastolic Blood Pressure J Curve.
20224 citationsauthor #4
Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
202212 citationsauthor #10
New Way to “SCORE” Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines
202216 citationsauthor #11
Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study.
20224 citationsauthor #12
Association of Cardiovascular Health Metrics with Risk of Transition to Hypertension in Non-Hypertensive Young Adults.
20223 citationsauthor #14
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association
2022183 citationsauthor #2
Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial.
20225 citationsauthor #19
Pollution and cardiovascular health: A contemporary review of morbidity and implications for planetary health
20227 citationsauthor #3
Mind the Gap: Primary Prevention Aspirin and the Danger of Suboptimal Implementation of Contemporary Guidelines Into Clinical Practice.
20221 citationsauthor #3
Isolated diastolic hypertension in the UK Biobank: correspondence regarding Isolated systolic and diastolic hypertension by the 2017 American College of Cardiology/American Heart Association guidelines and risk of cardiovascular disease: a large prospective cohort study
20221 citationsauthor #2
Major disparities in patient‐reported adherence compared to objective assessment of adherence using mass spectrometry: A prospective study in a tertiary‐referral hypertension clinic
202212 citationsauthor #9
Abstract P090: Utility Of High-sensitivity Cardiac Troponin T For Short-term Cardiovascular Risk Monitoring In The General Population
20220 citationsauthor #6
Abstract P109: Association Of The 2017 ACC/AHA Blood Pressure Guideline With Blood Pressure Change In Community-dwelling Older Adults Between 2016-2019: A Difference-in-differences Analysis In The ARIC Study
20220 citationsauthor #6
Elevated NT-proBNP as a cardiovascular disease risk equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study.
202218 citationsauthor #3
Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension-Con Side of the Argument.
20223 citationsauthor #5
Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?
20224 citationsauthor #2
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
202242 citationsauthor #21
Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension—Con Side of the Argument
202211 citationsauthor #5
Pulse Pressure Augmentation During Exercise: An Important Stress Test Parameter.
20220 citationsauthor #2
Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE.
20228 citationsauthor #3
Climate change and the prevention of cardiovascular disease
202233 citationsauthor #9
Isolated diastolic hypertension in the IDACO study.
202217 citationsauthor #2
Contextualizing National Policies Regulating Access to Low‐Dose Aspirin in America and Europe Using the Full Report of a Transatlantic Patient Survey of Aspirin in Preventive Cardiology
20223 citationsauthor #14
Glycated albuminandHbA1cas markers of lower extremity disease inUS adults with and without diabetes.
202212 citationsauthor #4
Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report).
20221 citationsauthor #8
Aspirin for cardiovascular disease prevention among adults in the United States: Trends, prevalence, and participant characteristics associated with use
202137 citationsauthor #7
INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions
202113 citationsauthor #1
A survey of general practitioners’ knowledge and clinical practice in relation to valvular heart disease
20215 citationsauthor #9
Association Between Omega‐3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA
202116 citationsauthor #9
Establishing target systolic and diastolic blood pressure in diabetic patients with hypertension: what do we need to consider?
20210 citationsauthor #2
Delirium in the intensive cardiovascular care unit
20210 citationsauthor #3
Impact of Body Composition Indices on Ten-year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial).
202110 citationsauthor #19
Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)
202111 citationsauthor #23
Gender Differences in Medicare Payments Among Cardiologists.
202118 citationsauthor #11
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
20214,472 citationsauthor #79
Higher Prevalence of Concurrent Thrombocytopenia in Patients Receiving Continuous Renal Replacement Therapy in the Cardiac Intensive Care Unit
20214 citationsauthor #10
Platelets and poppies: Do morphine and fentanyl differ?
20212 citationsauthor #3
Dietary and Lifestyle Modification for the Prevention and Treatment of Hypertension
20215 citationsauthor #5
Association of NT-proBNP, Blood Pressure, and Cardiovascular Events: Atherosclerosis Risk in Communities Study
20212 citationsauthor #5
Blood Pressure Limbo—How Low Can You Go?
20210 citationsauthor #2
Comparison of the Relation of Carotid Intima-Media Thickness with Incident Heart Failure with Reduced Versus Preserved Ejection Fraction (From the Multi-Ethnic Study of Atherosclerosis [MESA]).
20217 citationsauthor #12
ASPIRIN IN PREVENTIVE CARDIOLOGY: A TRANSATLANTIC ASSESSMENT OF PATIENT UNDERSTANDING
20210 citationsauthor #9
Observing the Patient Experience: Inside the Doctor’s Office in a Pandemic
20210 citationsauthor #3
TCT-116 Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
20213 citationsauthor #4
Letter by McEvoy Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
20212 citationsauthor #1
Hypertension guidelines and coronary artery calcification among South Asians: Results from MASALA and MESA
202115 citationsauthor #6
A Transatlantic Comparison of Patient-Reported Access to and Use of Aspirin in Contemporary Preventive Cardiology.
20214 citationsauthor #12
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
202150 citationsauthor #9
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
20211,164 citationsauthor #11
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
202172 citationsauthor #5
The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease
202120 citationsauthor #5
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
202162 citationsauthor #5
Implications of the 2021 ESC cardiovascular risk classification among 283,000 European immigrants living in a low-risk region: a population-based analysis in Catalonia
20211 citationsauthor #5
Are behaviour change techniques and intervention features associated with effectiveness of digital cardiac rehabilitation programmes? A systematic review protocol
20212 citationsauthor #2
Mobile health technologies to improve walking distance in people with intermittent claudication.
20212 citationsauthor #6
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
202147 citationsauthor #17
Aspirin in the Modern Era of Cardiovascular Disease Prevention
202131 citationsauthor #3
Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease
2020170 citationsauthor #5
High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes
202016 citationsauthor #5
27 What is the relationship between chronic kidney disease and subsequent events in a coronary heart disease population? A secondary analysis of the euroaspire V data
20200 citationsauthor #4
Abstract 14073: Omega-3 Fatty Acid Levels and Risk for Incident Bleeding and Atrial Fibrillation: Multi-Ethnic Study of Atherosclerosis (MESA)
20200 citationsauthor #9
ASSOCIATION OF NT-PROBNP, PULSE PRESSURE WITH HEART FAILURE AND CARDIOVASCULAR EVENTS: ATHEROSCLEROSIS RISK IN COMMUNNITIES (ARIC) STUDY
20200 citationsauthor #5
Isolated Diastolic Hypertension in the UK Biobank
202036 citationsauthor #6
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
202076 citationsauthor #18
A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
202034 citationsauthor #11
HYPERTENSION GUIDELINES AND CORONARY ARTERY CALCIFICATION AMONG SOUTH ASIANS: MEDIATORS OF ATHEROSCLEROSIS IN SOUTH ASIANS LIVING IN AMERICA (MASALA) AND MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)
20200 citationsauthor #6
Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (vol 74, e177, 209)
20209 citationsauthor #10
A Linear and Non-Linear Mendelian Randomization Analysis of the Association Between Diastolic Blood Pressure and Cardiovascular Events: The J Curve Revisited.
202075 citationsauthor #7
Ten-year all-cause mortality according to smoking status in patients with severe coronary artery disease undergoing surgical or percutaneous revascularization.
202013 citationsauthor #15
Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes.
2020127 citationsauthor #1
Pulse Pressure and Isolated Diastolic Hypertension-Reply.
20201 citationsauthor #1

TIMELINE

1992 0 citations

2005 0 citations

2008 216 citations

2010 330 citations

2011 105 citations

2012 324 citations

2013 529 citations

2014 400 citations

2015 1,212 citations

2016 1,186 citations

2017 712 citations

2018 915 citations

2019 6,482 citations

2020 1,328 citations

2021 6,077 citations

2022 404 citations

2023 528 citations

J. McEvoy

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT